Osteoporosis as a result of the long-term administration of glucocorticoids in patients suffering from acantholytic pemphigus
- Authors: Ufimtseva M.A.1, Bochkarev Y.M.1, Gurkovskaya E.P.1, Puhtinskaya P.S.1, Nikolaeva K.I.1, Lesnaya O.D.1
-
Affiliations:
- State budget educational institution of higher professional education "Ural State Medical University" of the Ministry of Health of the Russian Federation
- Issue: Vol 92, No 3 (2016)
- Pages: 56-61
- Section: ORIGINAL STUDIES
- URL: https://vestnikdv.ru/jour/article/view/239
- DOI: https://doi.org/10.25208/0042-4609-2016-92-3-56-61
Cite item
Full Text
Abstract
About the authors
M. A. Ufimtseva
State budget educational institution of higher professional education "Ural State Medical University" of the Ministry of Health of the Russian Federation
Author for correspondence.
Email: mail-m@mail.ru
Russian Federation
YU. M. Bochkarev
State budget educational institution of higher professional education "Ural State Medical University" of the Ministry of Health of the Russian Federation
Email: noemail@neicon.ru
Russian Federation
E. P. Gurkovskaya
State budget educational institution of higher professional education "Ural State Medical University" of the Ministry of Health of the Russian Federation
Email: noemail@neicon.ru
Russian Federation
P. S. Puhtinskaya
State budget educational institution of higher professional education "Ural State Medical University" of the Ministry of Health of the Russian Federation
Email: noemail@neicon.ru
Russian Federation
K. I. Nikolaeva
State budget educational institution of higher professional education "Ural State Medical University" of the Ministry of Health of the Russian Federation
Email: noemail@neicon.ru
Russian Federation
O. D. Lesnaya
State budget educational institution of higher professional education "Ural State Medical University" of the Ministry of Health of the Russian Federation
Email: noemail@neicon.ru
Russian Federation
References
- Минченко А.В., Чикин В.В., минеева А.А. Федеральные клинические рекомендации по ведению больных пузырчаткой. М: 2013
- Ghodsi S.Z., Shahram F. Osteoporosis in patients with Pemphigus Vulgaris before steroid therapy. Acta Med Iran 2014; 52 (12): 879-883.
- Woźniacka A., Torzecka J.D. The influence of corticosteroid treatment on the OPG/RANK/ RANKL pathway and osteocalcin in patients with pemphigus. Postepy Dermatol Alergol 2014; 31 (5): 281-288.
- Wohl Y., Dreiher J., Cohen A.D. Pemphigus and osteoporosis: a case-control study. JAMA Dermatology 2010; 146 (10): 1126-1131.
- Лесняк О.м., Баранова И.А., Торопцова Н.В. клинические рекомендации. Диагностика, профилактика и лечение глюкокортикоидного остеопороза у мужчин и женщин 18 лет и старше. Ярославль: Литера 2013; 2-27
- Alcaide-Martin A.J., Gallardo-Pérez M.A., et al. Epidemiologic study of 20 cases of pemphigus at Hospital Clinico Universitario Virgen de la Victoria de Malaga, Spain. Actas Dermosifiliogr 2010; 2: 524-533.
- Prubmann W., Prubmann J., Koga H. Prevalence of pemphigus and pemphigoid autoantibodies in the general population. Orphanet J Rare Diseases 2015.
- Sebaratnam D.F., McMillan J.R. Quality of life in patients with bullous dermatoses. Clini Dermatol 2012: 103-107.
- Uçmak D., Harman M., Uçmak F. The frequency of osteoporosis in patients with pemphigus vulgaris on treatment. Indi J Dermatol Venereol Leprol 2013. 2: 211-215.
- Лесняк О.М., Беневоленская Л.И. Остеопороз: диагностика, профилактика и лечение. м: ГОЭТАР-медиа 2010
